TickerFacts.

Mangoceuticals, Inc. (MGRX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$15.20M
As of 2025-12-31
$12.53M
As of 2026-06-30
+191.4%
3-year compound annual growth
2022-12-31: $614.0K2023-12-31: $774.8K2024-12-31: $13.95M2025-12-31: $15.20M$15.20M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$15.20M+9.0%2026-04-01, Balance as of period end
2024-12-31$13.95Mn/m2026-04-01, Balance as of period end
2023-12-31$774.8K+26.2%2025-03-20, Balance as of period end
2022-12-31$614.0Kn/a2024-04-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Mangoceuticals, Inc. (MGRX)2025-12-31$15.20M+9.0%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$356.7K-95.8%
Charming Medical Ltd (MCTA)2026-03-31$5.18Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$13.07M+11.9%
Marpai, Inc. (MRAI)2025-12-31-$32.56Mn/m
Cryo Cell International Inc (CCEL)2025-11-30-$18.61Mn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$141.54M+7.7%
Sotera Health Co (SHC)2025-12-31$606.03M+49.7%
Progyny, Inc. (PGNY)2025-12-31$516.04M+22.3%

Compare MGRX, BRTX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗